US Stock MarketDetailed Quotes

Supernus Pharmaceuticals (SUPN)

Watchlist
  • 50.000
  • -0.260-0.52%
Close Jan 16 16:00 ET
  • 49.890
  • -0.110-0.22%
Post 16:29 ET
2.87BMarket Cap-147.06P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Supernus Pharmaceuticals (SUPN) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-215.22%-61.66M
64.31%58.54M
-20.32%30.6M
54.79%171.95M
-1.23%44.41M
49.18%53.52M
288.75%35.62M
-21.83%38.4M
-4.91%111.09M
63.10%44.96M
Net income from continuing operations
-217.20%-45.12M
12.97%22.5M
-9,637.90%-11.83M
5,512.84%73.87M
1,204.51%15.33M
340.97%38.5M
2,496.63%19.92M
-99.27%124K
-97.83%1.32M
-95.39%1.18M
Operating gains losses
----
----
----
---9K
--0
----
----
----
----
----
Depreciation and amortization
23.40%24.81M
3.09%21.36M
-1.76%20.38M
-5.24%80.41M
-13.06%18.85M
-8.03%20.1M
-0.03%20.72M
0.72%20.75M
-0.80%84.86M
3.97%21.68M
Deferred tax
59.10%-2.65M
11.74%-7.16M
27.22%-3.99M
21.69%-20.14M
99.31%-72K
30.21%-6.47M
-46.11%-8.12M
-1,160.23%-5.48M
2.32%-25.71M
-34.78%-10.46M
Other non cash items
470.34%3.83M
232.59%1.95M
634.94%4.59M
-71.19%1.42M
133.24%1.59M
-58.11%671K
-121.80%-1.47M
-53.57%624K
140.30%4.91M
55.47%-4.79M
Change In working capital
-523.97%-49.2M
495.87%11.49M
0.30%13.91M
77.54%-2.05M
-359.83%-5.13M
-126.58%-7.89M
93.72%-2.9M
155.91%13.87M
58.74%-9.14M
113.19%1.97M
-Change in receivables
-200.64%-7.13M
201.03%4.81M
0.45%-3.56M
-88.93%2.08M
239.37%3.33M
236.03%7.09M
-208.35%-4.76M
-116.29%-3.58M
214.66%18.77M
-69.74%-2.39M
-Change in inventory
-381.06%-12.94M
-18.89%4.89M
137.74%4.73M
158.69%15.81M
-36.61%3.19M
-33.39%4.6M
251.42%6.03M
207.51%1.99M
134.21%6.11M
143.52%5.03M
-Change in prepaid assets
-535.71%-11.14M
-443.68%-2.5M
198.07%7.37M
-5,694.01%-19.35M
-238.52%-10.81M
-108.59%-1.75M
102.58%728K
-2,104.40%-7.52M
-102.71%-334K
-15.22%7.8M
-Change in payables and accrued expense
-0.91%-17.99M
187.79%4.3M
-76.64%5.37M
98.27%-584K
90.12%-837K
-335.71%-17.82M
73.41%-4.9M
259.95%22.97M
-15,070.27%-33.68M
36.37%-8.47M
Cash from discontinued investing activities
Operating cash flow
-215.22%-61.66M
64.31%58.54M
-20.32%30.6M
54.79%171.95M
-1.23%44.41M
49.18%53.52M
288.75%35.62M
-21.83%38.4M
-4.91%111.09M
63.10%44.96M
Investing cash flow
Cash flow from continuing investing activities
163.25%48.71M
37.01%-30.61M
172.29%37.32M
-170.65%-189.87M
80.85%-12.64M
-322.36%-77.01M
-180.59%-48.59M
-121.53%-51.62M
224.03%268.73M
-35.30%-65.98M
Net PPE purchase and sale
35.50%-129K
-610.94%-455K
-31.85%-327K
-31.58%-725K
-691.67%-213K
-33.33%-200K
59.75%-64K
10.79%-248K
-33.74%-551K
260.00%36K
Net investment purchase and sale
545.15%341.93M
37.87%-30.15M
173.27%37.64M
-170.24%-189.14M
81.18%-12.43M
-320.82%-76.81M
-180.27%-48.53M
-121.40%-51.38M
224.52%269.28M
-35.35%-66.02M
Cash from discontinued investing activities
Investing cash flow
163.25%48.71M
37.01%-30.61M
172.29%37.32M
-170.65%-189.87M
80.85%-12.64M
-322.36%-77.01M
-180.59%-48.59M
-121.53%-51.62M
224.03%268.73M
-35.30%-65.98M
Financing cash flow
Cash flow from continuing financing activities
585.14%21.07M
-43.61%935K
-1,462.99%-21.4M
103.06%12.19M
439.38%5.89M
1,436.96%3.08M
100.35%1.66M
-98.04%1.57M
-3,697.65%-397.88M
-61.40%1.09M
Net issuance payments of debt
----
----
----
--0
--0
--0
--0
--0
---402.5M
--0
Net common stock issuance
585.76%23.74M
97.47%3.28M
-29.83%2.04M
125.54%14.91M
529.76%6.88M
367.84%3.46M
-34.22%1.66M
28.99%2.91M
-46.79%6.61M
-61.40%1.09M
Net other financing activities
-590.70%-2.67M
-234,000.00%-2.34M
-1,649.33%-23.44M
-36.43%-2.72M
---987K
60.10%-387K
99.83%-1K
-201.12%-1.34M
91.31%-1.99M
--0
Cash from discontinued financing activities
Financing cash flow
585.14%21.07M
-43.61%935K
-1,462.99%-21.4M
103.06%12.19M
439.38%5.89M
1,436.96%3.08M
100.35%1.66M
-98.04%1.57M
-3,697.65%-397.88M
-61.40%1.09M
Net cash flow
Beginning cash position
177.81%144.71M
82.72%115.85M
-7.63%69.33M
-19.40%75.05M
-66.65%31.67M
110.84%52.09M
-86.28%63.4M
-19.40%75.05M
-54.23%93.12M
-14.81%94.99M
Current changes in cash
139.72%8.11M
355.15%28.86M
499.18%46.52M
68.32%-5.72M
288.94%37.66M
-129.05%-20.42M
97.41%-11.31M
-103.16%-11.65M
83.62%-18.07M
-8.49%-19.93M
End cash Position
382.50%152.82M
177.81%144.71M
82.72%115.85M
-7.63%69.33M
-7.63%69.33M
-66.65%31.67M
110.84%52.09M
-86.28%63.4M
-19.40%75.05M
-19.40%75.05M
Free cash flow
-215.89%-61.79M
63.33%58.08M
-20.66%30.27M
54.91%171.23M
-1.78%44.19M
49.25%53.32M
286.83%35.56M
-21.89%38.15M
-5.05%110.53M
63.18%44.99M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -215.22%-61.66M64.31%58.54M-20.32%30.6M54.79%171.95M-1.23%44.41M49.18%53.52M288.75%35.62M-21.83%38.4M-4.91%111.09M63.10%44.96M
Net income from continuing operations -217.20%-45.12M12.97%22.5M-9,637.90%-11.83M5,512.84%73.87M1,204.51%15.33M340.97%38.5M2,496.63%19.92M-99.27%124K-97.83%1.32M-95.39%1.18M
Operating gains losses ---------------9K--0--------------------
Depreciation and amortization 23.40%24.81M3.09%21.36M-1.76%20.38M-5.24%80.41M-13.06%18.85M-8.03%20.1M-0.03%20.72M0.72%20.75M-0.80%84.86M3.97%21.68M
Deferred tax 59.10%-2.65M11.74%-7.16M27.22%-3.99M21.69%-20.14M99.31%-72K30.21%-6.47M-46.11%-8.12M-1,160.23%-5.48M2.32%-25.71M-34.78%-10.46M
Other non cash items 470.34%3.83M232.59%1.95M634.94%4.59M-71.19%1.42M133.24%1.59M-58.11%671K-121.80%-1.47M-53.57%624K140.30%4.91M55.47%-4.79M
Change In working capital -523.97%-49.2M495.87%11.49M0.30%13.91M77.54%-2.05M-359.83%-5.13M-126.58%-7.89M93.72%-2.9M155.91%13.87M58.74%-9.14M113.19%1.97M
-Change in receivables -200.64%-7.13M201.03%4.81M0.45%-3.56M-88.93%2.08M239.37%3.33M236.03%7.09M-208.35%-4.76M-116.29%-3.58M214.66%18.77M-69.74%-2.39M
-Change in inventory -381.06%-12.94M-18.89%4.89M137.74%4.73M158.69%15.81M-36.61%3.19M-33.39%4.6M251.42%6.03M207.51%1.99M134.21%6.11M143.52%5.03M
-Change in prepaid assets -535.71%-11.14M-443.68%-2.5M198.07%7.37M-5,694.01%-19.35M-238.52%-10.81M-108.59%-1.75M102.58%728K-2,104.40%-7.52M-102.71%-334K-15.22%7.8M
-Change in payables and accrued expense -0.91%-17.99M187.79%4.3M-76.64%5.37M98.27%-584K90.12%-837K-335.71%-17.82M73.41%-4.9M259.95%22.97M-15,070.27%-33.68M36.37%-8.47M
Cash from discontinued investing activities
Operating cash flow -215.22%-61.66M64.31%58.54M-20.32%30.6M54.79%171.95M-1.23%44.41M49.18%53.52M288.75%35.62M-21.83%38.4M-4.91%111.09M63.10%44.96M
Investing cash flow
Cash flow from continuing investing activities 163.25%48.71M37.01%-30.61M172.29%37.32M-170.65%-189.87M80.85%-12.64M-322.36%-77.01M-180.59%-48.59M-121.53%-51.62M224.03%268.73M-35.30%-65.98M
Net PPE purchase and sale 35.50%-129K-610.94%-455K-31.85%-327K-31.58%-725K-691.67%-213K-33.33%-200K59.75%-64K10.79%-248K-33.74%-551K260.00%36K
Net investment purchase and sale 545.15%341.93M37.87%-30.15M173.27%37.64M-170.24%-189.14M81.18%-12.43M-320.82%-76.81M-180.27%-48.53M-121.40%-51.38M224.52%269.28M-35.35%-66.02M
Cash from discontinued investing activities
Investing cash flow 163.25%48.71M37.01%-30.61M172.29%37.32M-170.65%-189.87M80.85%-12.64M-322.36%-77.01M-180.59%-48.59M-121.53%-51.62M224.03%268.73M-35.30%-65.98M
Financing cash flow
Cash flow from continuing financing activities 585.14%21.07M-43.61%935K-1,462.99%-21.4M103.06%12.19M439.38%5.89M1,436.96%3.08M100.35%1.66M-98.04%1.57M-3,697.65%-397.88M-61.40%1.09M
Net issuance payments of debt --------------0--0--0--0--0---402.5M--0
Net common stock issuance 585.76%23.74M97.47%3.28M-29.83%2.04M125.54%14.91M529.76%6.88M367.84%3.46M-34.22%1.66M28.99%2.91M-46.79%6.61M-61.40%1.09M
Net other financing activities -590.70%-2.67M-234,000.00%-2.34M-1,649.33%-23.44M-36.43%-2.72M---987K60.10%-387K99.83%-1K-201.12%-1.34M91.31%-1.99M--0
Cash from discontinued financing activities
Financing cash flow 585.14%21.07M-43.61%935K-1,462.99%-21.4M103.06%12.19M439.38%5.89M1,436.96%3.08M100.35%1.66M-98.04%1.57M-3,697.65%-397.88M-61.40%1.09M
Net cash flow
Beginning cash position 177.81%144.71M82.72%115.85M-7.63%69.33M-19.40%75.05M-66.65%31.67M110.84%52.09M-86.28%63.4M-19.40%75.05M-54.23%93.12M-14.81%94.99M
Current changes in cash 139.72%8.11M355.15%28.86M499.18%46.52M68.32%-5.72M288.94%37.66M-129.05%-20.42M97.41%-11.31M-103.16%-11.65M83.62%-18.07M-8.49%-19.93M
End cash Position 382.50%152.82M177.81%144.71M82.72%115.85M-7.63%69.33M-7.63%69.33M-66.65%31.67M110.84%52.09M-86.28%63.4M-19.40%75.05M-19.40%75.05M
Free cash flow -215.89%-61.79M63.33%58.08M-20.66%30.27M54.91%171.23M-1.78%44.19M49.25%53.32M286.83%35.56M-21.89%38.15M-5.05%110.53M63.18%44.99M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.11%
Sample Name
Sample Code
 +2.53%
Sample Name
Sample Code
 +2.08%
4
Tempus AI
TEM
+2.05%
5
Block
XYZ
+1.59%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.35%
Sample Name
Sample Code
 +10.03%
Sample Name
Sample Code
 +9.57%
4
Kingsoft Cloud
KC
+7.99%
5
United Microelectronics
UMC
+5.80%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -